It is best to combine medication with lifestyle changes if your goal is to lose excess weight and keep it off
Characteristics of elderly patients initiating sitagliptin or non-DPP-4-inhibitor oral antihyperglycemic agents: analysis of a cross-sectional US claims database
Go, VLW, Hofmann, AF, Summerskill, WHJ
Clinical evidence supports its use for chemotherapy-induced nausea, and many semaglutide users report benefit
DePasquale, this letter typically must include: Diagnosis codes Body mass index (BMI) and weight trend Comorbidities Relevant labs and vitals Documentation of failed or insufficient response to lifestyle therapy and any prior weight-loss medications Current medications Risk profiles (e.g., OSA, prediabetes, diabetes, non-alcoholic fatty liver disease, and how weight loss will change outcomes) Your Medicaid program or managed Medicaid plan will inform the prescriber if any additional information is needed
Individual results may vary, and some may achieve even greater weight loss